---
category: corporate-action
circular_id: 64447de3c780084f
date: '2025-12-22'
description: Nectar Lifesciences Limited has fixed December 24, 2025 as the record
  date to determine shareholders eligible to participate in the buyback offer.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={20A09AF9-940E-4695-A143-9904D0AA48C7}&noticeno=20251222-10&dt=12/22/2025&icount=10&totcount=27&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Buyback announcement affects only shareholders of Nectar Lifesciences
  Limited with specific record date for eligibility determination
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251222-10&attachedId=
processing:
  attempts: 1
  content_hash: 5c1e310619e0db45
  processed_at: '2025-12-22T12:59:44.082840'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-22T08:13:39+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={20A09AF9-940E-4695-A143-9904D0AA48C7}&noticeno=20251222-10&dt=12/22/2025&icount=10&totcount=27&flag=0
severity: medium
source: bse
stocks:
- NECTAR
tags:
- buyback
- tender-offer
- corporate-action
- record-date
- equity-shares
- NECTAR
title: Tender Offer (Buyback) of Equity Shares of Nectar Lifesciences Limited
---

## Summary

Nectar Lifesciences Limited (Scrip Code: 532649) has announced a buyback of equity shares and fixed the record date as December 24, 2025. The record date determines which shareholders are eligible to participate in the tender offer. The ex-entitlement date is also December 24, 2025 (Settlement No. DR-784/2025-2026).

## Key Points

- Company: Nectar Lifesciences Limited (Scrip Code: 532649)
- Record Date: December 24, 2025
- Purpose: Determine entitlement and names of equity shareholders eligible for buyback participation
- Ex-Entitlement Date: December 24, 2025
- Settlement Number: DR-784/2025-2026
- Segment: Dematerialised Securities â€“ Rolling Settlement

## Regulatory Changes

No regulatory changes announced. This is a standard corporate action notification.

## Compliance Requirements

- Trading members must note the record date and ex-entitlement date
- Only shareholders holding shares on the record date (December 24, 2025) will be eligible to participate in the buyback
- Shares will trade on ex-entitlement basis from December 24, 2025

## Important Dates

- **Notice Date**: December 22, 2025
- **Record Date**: December 24, 2025
- **Ex-Entitlement Date**: December 24, 2025
- **Settlement Number**: DR-784/2025-2026

## Impact Assessment

**Market Impact**: Medium - The buyback announcement may lead to increased trading activity in Nectar Lifesciences shares as investors assess participation eligibility. Shares will trade ex-entitlement from December 24, 2025.

**Shareholder Impact**: Medium - Only shareholders on record as of December 24, 2025 can participate in the buyback offer. Investors purchasing shares on or after the ex-entitlement date will not be eligible.

**Operational Impact**: Low - Standard corporate action processing for trading members and depositories.